All Stories

  1. Assessment of Population Immunity Against Peste des Petits Ruminants in Goats and Sheep in India After the Second Annual Mass Vaccination Implemented Under the National PPR Eradication Programme
  2. Molecular Characterization of Lineage IV Peste des Petits Ruminants Viruses in Sudan Isolated from Outbreaks Between 2015 and 2018 Suggests the Existence of the North–East Africa Episystem
  3. Foot and Mouth Disease Vaccine Strain Selection– Vaccine Manufacturers’ Perspectives
  4. Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance
  5. A Scoping Review on Progression Towards Freedom from Peste des Petits Ruminants (PPR) and the Role of the PPR Monitoring and Assessment Tool (PMAT)
  6. Mapping novel antigenic determinants on foot-and-mouth disease virus serotype Asia 1 using neutralising monoclonal antibody resistant mutants
  7. Current Advances in Genetic Detection and Nanopore Sequencing of Peste des Petits Ruminants Virus
  8. PPR Infection Crossing Between Domestic and Wild Hoofed Mammals: Does This Matter for Virus Eradication?
  9. Seroprevalence of peste des petits ruminants in sheep and goats managed under pastoral and agro-pastoral systems
  10. Update on peste des petits ruminants in Europe
  11. Post-Vaccination Sero-Monitoring of Peste des Petits Ruminants in Sheep and Goats in Karnataka: Progress towards PPR Eradication in India
  12. Evaluation of a novel liquid stabilised peste des petits ruminants vaccine: Safety and immunogenic efficacy in sheep and goats in the field in Jordan
  13. The evaluation of five serological assays in determining seroconversion to peste des petits ruminants virus in typical and atypical hosts
  14. Peste Des Petits Ruminants Screening and Diagnostic Tests in African Wildlife in the Context of Rinderpest Eradication (1994–2007)
  15. Towards Eradication of PPR: Disease Status, Economic Cost and Perception of Veterinarians in Karnataka, India
  16. Peste des Petits Ruminants in Central and Eastern Asia/West Eurasia: Epidemiological Situation and Status of Control and Eradication Activities after the First Phase of the PPR Global Eradication Programme (2017–2021)
  17. Development and Evaluation of Molecular Pen-Side Assays without Prior RNA Extraction for Peste des Petits Ruminants (PPR) and Foot and Mouth Disease (FMD)
  18. Retrospective Characterization of Initial Peste des petits ruminants Outbreaks (2008–2012) in the Democratic Republic of the Congo
  19. Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR
  20. Development and Evaluation of a Nested PCR for Improved Diagnosis and Genetic Analysis of Peste des Petits Ruminants Virus (PPRV) for Future Use in Nascent PPR Eradication Programme
  21. Ongoing Assessment of the Molecular Evolution of Peste Des Petits Ruminants Virus Continues to Question Viral Origins
  22. Complete Genome Sequencing of Field Isolates of Peste des Petits Ruminants Virus from Tanzania Revealed a High Nucleotide Identity with Lineage III PPR Viruses
  23. Molecular Basis of Antigenic Drift in Serotype O Foot-and-Mouth Disease Viruses (2013–2018) from Southeast Asia
  24. Environmental sampling for the detection of foot‐and‐mouth disease virus and peste des petits ruminants virus in a live goat market, Nepal
  25. Development of Nanobodies Targeting Peste des Petits Ruminants Virus: The Prospect in Disease Diagnosis and Therapy
  26. Development and Validation of Confirmatory Foot-and-Mouth Disease Virus Antibody ELISAs to Identify Infected Animals in Vaccinated Populations
  27. Peste des Petits Ruminants Virus Infection at the Wildlife–Livestock Interface in the Greater Serengeti Ecosystem, 2015–2019
  28. Development and Validation of a Mucosal Antibody (IgA) Test to Identify Persistent Infection with Foot-and-Mouth Disease Virus
  29. Progress towards Eradication of Peste des Petits Ruminants through Vaccination
  30. RNAseq Reveals the Contribution of Interferon Stimulated Genes to the Increased Host Defense and Decreased PPR Viral Replication in Cattle
  31. Comparison of Immunogenicity and Protective Efficacy of PPR Live Attenuated Vaccines (Nigeria 75/1 and Sungri 96) Administered by Intranasal and Subcutaneous Routes
  32. Characterisation of Peste Des Petits Ruminants Disease in Pastoralist Flocks in Ngorongoro District of Northern Tanzania and Bluetongue Virus Co-Infection
  33. Detection of Bovine Antibodies against a Conserved Capsid Epitope as the Basis of a Novel Universal Serological Test for Foot-and-Mouth Disease
  34. Eradication of Peste des Petits Ruminants Virus and the Wildlife-Livestock Interface
  35. Peste des Petits Ruminants at the Wildlife–Livestock Interface in the Northern Albertine Rift and Nile Basin, East Africa
  36. Outbreak of Peste des Petits Ruminants among Critically Endangered Mongolian Saiga and Other Wild Ungulates, Mongolia, 2016–2017
  37. Detection of antibodies against a conserved capsid epitope as the basis of a novel universal serological test for foot-and-mouth disease
  38. Rapid Detection of Peste des Petits Ruminants Virus (PPRV) Nucleic Acid Using a Novel Low-Cost Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) Assay for Future Use in Nascent PPR Eradication Programme
  39. Identification of novel epitopes in serotype O foot-and-mouth disease virus by in vitro immune selection
  40. Optimization and evaluation of a non-invasive tool for peste des petits ruminants surveillance and control
  41. Quantifying Levels of Peste Des Petits Ruminants (PPR) Virus in Excretions from Experimentally Infected Goats and Its Importance for Nascent PPR Eradication Programme
  42. Molecular characterization of Peste des petits ruminants viruses in the Marmara Region of Turkey
  43. Detection of foot-and-mouth disease virus in milk samples by real-time reverse transcription polymerase chain reaction: Optimisation and evaluation of a high-throughput screening method with potential for disease surveillance
  44. Monoclonal antibody resistant mutant of Peste des petits ruminants vaccine virus
  45. Waves of endemic foot-and-mouth disease in eastern Africa suggest feasibility of proactive vaccination approaches
  46. Foot and mouth disease vaccine strain selection: current approaches and future perspectives
  47. Molecular detection, isolation and characterization of Peste-des-petits ruminants virus from goat milk from outbreaks in Bangladesh and its implication for eradication strategy
  48. Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain
  49. Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007–2012) circulating in Southeast Asia, East Asia and Far East
  50. Persistence of Lineage IV Peste-des-petits ruminants virus within Israel since 1993: An evolutionary perspective
  51. Peste des petits ruminants (PPR): A neglected tropical disease in Maghreb region of North Africa and its threat to Europe
  52. Re-emergence of Peste des Petits Ruminants virus in 2015 in Morocco: Molecular characterization and experimental infection in Alpine goats
  53. Tracking the Antigenic Evolution of Foot-and-Mouth Disease Virus
  54. Emergence of antigenic variants within serotype A FMDV in the Middle East with antigenically critical amino acid substitutions
  55. Spillover of Peste des Petits Ruminants Virus from Domestic to Wild Ruminants in the Serengeti Ecosystem, Tanzania
  56. Peste des petits ruminants
  57. Detection and Genetic Characterization of Lineage IV Peste Des Petits Ruminant Virus in Kazakhstan
  58. Serological Detection of Antibodies to Peste des Petits Ruminants Virus in Large Ruminants
  59. Complete Genome Sequences of Serotype O Foot-and-Mouth Disease Viruses Recovered from Experimental Persistently Infected Cattle
  60. Virus Excretion from Foot-And-Mouth Disease Virus Carrier Cattle and Their Potential Role in Causing New Outbreaks
  61. Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis
  62. Development of a Competitive Enzyme-Linked Immunosorbent Assay for Detection of Antibodies against the 3B Protein of Foot-and-Mouth Disease Virus
  63. Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses
  64. Rescue of a vaccine strain of peste des petits ruminants virus: In vivo evaluation and comparison with standard vaccine
  65. Serological profile of foot-and-mouth disease in wildlife populations of West and Central Africa with special reference to Syncerus caffer subspecies
  66. Pathology of Peste des Petits Ruminants
  67. Molecular Epidemiology of Peste des Petits Ruminants Virus
  68. Vaccines Against Peste des Petits Ruminants Virus
  69. Molecular Evolution of Peste des Petits Ruminants Virus
  70. Peste des Petits Ruminants Virus, Eastern Asia
  71. Molecular characterization of peste-des-petits ruminants virus (PPRV) isolated from an outbreak in the Indo-Bangladesh border of Tripura state of North-East India
  72. Emergence of Lineage IV Peste des Petits Ruminants Virus in Ethiopia: Complete Genome Sequence of an Ethiopian Isolate 2010
  73. Toll-Like Receptor Responses to Peste des petits ruminants Virus in Goats and Water Buffalo
  74. Molecular characterisation of lineage IV peste des petits ruminants virus using multi gene sequence data
  75. Complete Genome Sequences of Lineage III Peste des Petits Ruminants Viruses from the Middle East and East Africa
  76. Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains
  77. Transmission of foot-and-mouth disease virus from experimentally infected Indian buffalo (Bubalus bubalis) to in-contact naïve and vaccinated Indian buffalo and cattle
  78. Detection of subclinical peste des petits ruminants virus infection in experimental cattle
  79. Morbillivirus vaccines: Recent successes and future hopes
  80. Characteristics of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion in experimentally infected cattle
  81. Patterns of Foot-and-Mouth Disease Virus Distribution in Africa
  82. Evolutionary genetics underlying the spread of peste des petits ruminants virus
  83. Peste des Petits Ruminants Infection among Cattle and Wildlife in Northern Tanzania
  84. Early Events following Experimental Infection with Peste-Des-Petits Ruminants Virus Suggest Immune Cell Targeting
  85. Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity
  86. Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid serotyping of foot-and-mouth disease virus
  87. Interferon-γ Induced by In Vitro Re-Stimulation of CD4+ T-Cells Correlates with In Vivo FMD Vaccine Induced Protection of Cattle against Disease and Persistent Infection
  88. Complete Genome Sequence of a Peste des Petits Ruminants Virus Recovered from Wild Bharal in Tibet, China
  89. A Reliable and Reproducible Experimental Challenge Model for Peste des Petits Ruminants Virus
  90. A novel approach to generating morbillivirus vaccines: Negatively marking the rinderpest vaccine
  91. Field application of a recombinant protein-based ELISA during the 2010 outbreak of foot-and-mouth disease type A in South Korea
  92. Peste des petits ruminants: a suitable candidate for eradication?
  93. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen
  94. Molecular Characterisation of Foot-and-Mouth Disease Viruses from Pakistan, 2005-2008
  95. Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control
  96. Vaccines against peste des petits ruminants virus
  97. Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve
  98. Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza
  99. The effect of vaccination on undetected persistence of foot-and-mouth disease virus in cattle herds and sheep flocks
  100. Vaccination against foot-and-mouth disease virus: strategies and effectiveness
  101. Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site
  102. Emergency vaccination of sheep against foot-and-mouth disease: Significance and detection of subsequent sub-clinical infection
  103. Serological Survey for Foot-and-Mouth Disease Virus in Wildlife in Eastern Africa and Estimation of Test Parameters of a Nonstructural Protein Enzyme-Linked Immunosorbent Assay for Buffalo
  104. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge
  105. Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge
  106. Use of a Standardized Bovine Serum Panel To Evaluate a Multiplexed Nonstructural Protein Antibody Assay for Serological Surveillance of Foot-and-Mouth Disease
  107. Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine
  108. Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies
  109. Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus
  110. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle
  111. Matrix protein and glycoproteins F and H of Peste-des-petits-ruminants virus function better as a homologous complex
  112. Importance of the extracellular and cytoplasmic/transmembrane domains of the haemagglutinin protein of rinderpest virus for recovery of viable virus from cDNA copies
  113. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle
  114. Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance
  115. Interferon-γ production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV
  116. Utility of automated real-time RT-PCR for the detection of foot-and-mouth disease virus excreted in milk
  117. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease
  118. The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes
  119. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx
  120. Sequence analysis of the phosphoprotein gene of peste des petits ruminants (PPR) virus: editing of the gene transcript
  121. Rinderpest virus lineage differentiation using RT-PCR and SNAP-ELISA
  122. Contribution of epidemiological knowledge and control strategies in the eradication of rinderpest virus.